Andrew Cavanna is a Partner in the healthcare team. He joined Apax in 2017 and is currently based in New York. Andrew has led and participated in key deals including InnovAge, Kepro, and Genex.
Prior to joining Apax, Andrew spent eleven years at Vestar Capital Partners where he was a Managing Director and Co-Head of the Healthcare Sector. At Vestar, Andrew was involved with a number of investments including Press Ganey, Essent Healthcare, StayWell, Joerns Healthcare, Sunrise Medical, Institutional Shareholder Services (ISS) and Veritas Collaborative. Andrew came to Vestar in 2006 from The Blackstone Group. Prior to Blackstone, Andrew was a Senior Associate at JPMorgan Partners. Andrew started his career as an Analyst in Leveraged Finance at Merrill Lynch.
Andrew holds an MBA from Columbia Business School and a BA, cum laude, in Economics and Government from Cornell University.
Andrew serves on the board of Kepro and InnovAge and previously served on the board of Genex.
Andrew is a Board Member of the Cornell College of Arts and Sciences Advisory Council.
Andy and his family live in his hometown alongside his parents, siblings and lots of nieces and nephews. He did manage to make it out for a few years to attend college in upstate New York, where he became intrigued with development economics and the interplay of business and government policy. This interest led to a focus on investing in the healthcare industry early in his professional career. Today he is passionate about working with his colleagues around the world to build more valuable healthcare companies that make a positive impact on people’s lives.